These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 34590710

  • 21. Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.
    Ouchari M, Srivastava K, Romdhane H, Jemni Yacoub S, Flegel WA.
    Transfusion; 2018 Feb; 58(2):306-312. PubMed ID: 29193104
    [Abstract] [Full Text] [Related]

  • 22. Machine learning to optimize automated RH genotyping using whole-exome sequencing data.
    Chang TC, Yu J, Wang Z, Hankins JS, Weiss MJ, Wu G, Westhoff CM, Chou ST, Zheng Y.
    Blood Adv; 2024 Jun 11; 8(11):2651-2659. PubMed ID: 38522094
    [Abstract] [Full Text] [Related]

  • 23. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients.
    Dezan MR, Ribeiro IH, Oliveira VB, Vieira JB, Gomes FC, Franco LAM, Varuzza L, Ribeiro R, Chinoca KZ, Levi JE, Krieger JE, Pereira AC, Gualandro SFM, Rocha VG, Mendrone-Junior A, Sabino EC, Dinardo CL.
    Blood Cells Mol Dis; 2017 Jun 11; 65():8-15. PubMed ID: 28388467
    [Abstract] [Full Text] [Related]

  • 24. Identification of a novel frequent RHCE*ce308T variant allele in Chinese D- individuals, resulting in a C+c- phenotype.
    Stegmann TC, Ji Y, Bijman R, Wang Z, Wen J, Wei L, Veldhuisen B, Haer-Wigman L, Lighthart P, Lodén-van Straaten M, Luo G, van der Schoot CE.
    Transfusion; 2016 Sep 11; 56(9):2314-21. PubMed ID: 27338008
    [Abstract] [Full Text] [Related]

  • 25. Serological screening and genetic analysis of RhCE variants in the Chinese Southern Han donors.
    Jia S, Chen J, Wen J, Wang Z, Wei L, Fu Y, Luo G, Ji Y.
    Transfus Med; 2021 Aug 11; 31(4):271-276. PubMed ID: 33998062
    [Abstract] [Full Text] [Related]

  • 26. RHCE and Kell genotyping and alloimmunization profile in patients with sickle cell disease in the Federal District of Brazil.
    Leite LE, da Silva FG, Kashima S, Rodrigues ES, Haddad R.
    Hematol Transfus Cell Ther; 2024 Aug 11; 46(3):261-267. PubMed ID: 37344342
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Identification of six new RHCE variant alleles in individuals of diverse racial origin.
    Goldman M, Cemborain A, Cote J, El Hamss R, Flower RL, Garaizar A, Garcia-Sanchez F, Hyland CA, Kalvelage M, Londero D, Lopez GH, Revelli N, Rodriguez-Wilhelmi P, Villa A, Ochoa-Garay G.
    Transfusion; 2016 Jan 11; 56(1):244-8. PubMed ID: 26435076
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. How do I incorporate red cell genotyping to improve chronic transfusion therapy?
    Van Buren NL, Gorlin JB, Corby SM, Cassidy S, FritchLilla S, Nelson SC, Westhoff CM.
    Transfusion; 2020 Jan 11; 60(1):16-25. PubMed ID: 31758587
    [Abstract] [Full Text] [Related]

  • 32. First investigation of RH gene polymorphism in patients with sickle cell disease and associated blood donors in Cameroon, Central Africa.
    Mbeti JMM, Bénech C, Sack FN, Wete E, Pangetha HN, Ateba SN, Tchatchueng J, Nloga AN, Fichou Y.
    Blood Transfus; 2024 Sep 11; 22(5):377-386. PubMed ID: 38315540
    [Abstract] [Full Text] [Related]

  • 33. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes.
    Cruz BR, Chiba AK, Moritz E, Bordin JO.
    Transfus Med; 2012 Apr 11; 22(2):84-9. PubMed ID: 22211984
    [Abstract] [Full Text] [Related]

  • 34. Management of a patient with sickle cell disease and multiple red blood cell alloantibodies in preparation for a hematopoietic stem cell transplantation.
    Cigna M, Leiva-Torres GA, Baillargeon N, Yanez JC, Robitaille N.
    Transfusion; 2024 Mar 11; 64(3):554-559. PubMed ID: 38205646
    [Abstract] [Full Text] [Related]

  • 35. RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification.
    Haer-Wigman L, Veldhuisen B, Jonkers R, Lodén M, Madgett TE, Avent ND, de Haas M, van der Schoot CE.
    Transfusion; 2013 Jul 11; 53(7):1559-74. PubMed ID: 23043317
    [Abstract] [Full Text] [Related]

  • 36. New RHCE variant alleles encoding the D- - phenotype.
    Ochoa-Garay G, Moulds JM, Cote J, Kresie L, Garaizar A, Goldman M, Wynn P.
    Transfusion; 2013 Nov 11; 53(11 Suppl 2):3018-23. PubMed ID: 24020803
    [Abstract] [Full Text] [Related]

  • 37. RHD and RHCE molecular analysis in weak D blood donors and in patients with Rh antibodies against their own corresponding Rh antigen.
    Souza Silva TC, Cruz BR, Costa SS, Chiba AK, Barros MMO, Langhi DM, Bordin JO.
    Blood Transfus; 2020 Jul 11; 18(4):295-303. PubMed ID: 32697929
    [Abstract] [Full Text] [Related]

  • 38. Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease.
    Chou ST, Westhoff CM.
    Hematology Am Soc Hematol Educ Program; 2009 Jul 11; ():178-84. PubMed ID: 20008197
    [Abstract] [Full Text] [Related]

  • 39. RhCE protein variants in Southwestern Germany detected by serologic routine testing.
    Bugert P, Scharberg EA, Geisen C, von Zabern I, Flegel WA.
    Transfusion; 2009 Sep 11; 49(9):1793-802. PubMed ID: 19453980
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of the applicability and effectiveness of a molecular strategy for identifying weak D and DEL phenotype among D- blood donors of mixed origin exhibiting high frequency of RHD*Ψ.
    Dezan MR, Guardalini LGO, Pessoa E, Ribeiro IH, Oliveira VB, Luz F, Novac DR, Gallucci A, Bonifácio S, Gomes F, Levi JE, Pereira AC, Krieger JE, Mendrone-Junior A, Rocha V, Dinardo CL.
    Transfusion; 2018 Feb 11; 58(2):317-322. PubMed ID: 29193119
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.